• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Cardiff Oncology(CRDF.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec8
Cardiff Oncology to present new clinical data on onvansertib at ASH annual meeting
21:05
Nov7
Cardiff Oncology released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 120 K (forecast USD 121.43 K), actual EPS USD -0.1684 (forecast USD -0.205)
04:00
Cardiff Oncology released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 350K, actual EPS USD -0.5801
04:00
Jul30
Cardiff Oncology released FY2025 Semi-Annual earnings on July 29 (EST), actual revenue USD 230K, actual EPS USD -0.4117
03:00
Cardiff Oncology released FY2025 Q2 earnings on July 29, 2025 (EST), with actual revenue of USD 121 K (forecast USD 106.25 K) and actual EPS of USD -0.2096 (forecast USD -0.1925)
03:00
Jun26
Cardiff Oncology Annual Shareholder Meeting Appoints Registered Independent Auditor and Amends Equity Incentive Plan
20:31

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 120 K, Net Income -11.26 M, EPS -0.1684

Jul29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 121 K, Net Income -13.95 M, EPS -0.2096

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 109 K, Net Income -13.44 M, EPS -0.202

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
33.960
+76.14%
+14.680
RGC
52.880
+60.10%
+19.850
NVVE
3.510
+59.55%
+1.310
CELG.RT
0.1110
+58.80%
+0.041
LUCY
1.740
+47.46%
+0.560
GLUE
23.280
+45.41%
+7.270
PELIR
0.4000
+44.93%
+0.124
IPSC
1.300
+44.44%
+0.400
NBY
10.640
+43.98%
+3.250
ERAS
5.170
+42.42%
+1.540
View More